MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY

被引:1250
作者
BARAK, Y
JUVEN, T
HAFFNER, R
OREN, M
机构
[1] Department of Chemical Immunology, The Weizmann Institute of Science
关键词
GROWTH CONTROL; MDM2; P53; TUMOR SUPPRESSOR;
D O I
10.1002/j.1460-2075.1993.tb05678.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have recently characterized a 95 kDa protein, p95, which exhibits enhanced binding to temperature-sensitive p53 (ts-p53) when cells are shifted down to 32.5-degrees-C, a temperature at which ts-p53 possesses wild-type (wt)-like activities. In the present study we show that p95 is a product of the mdm2 putative proto-oncogene. The enhanced complex formation of mdm2 with ts-p53 in cells maintained at 32.5-degrees-C is due to an elevation in total mdm2 protein levels following the temperature shift. We further demonstrate that the induction of mdm2 expression by wt p53 activity is at the mRNA level. The induction occurs with very rapid kinetics and does not require de novo protein synthesis, suggesting a direct involvement of p53 in the process. Based on these data and on recent findings implicating p53 as a transcription factor, we suggest that the mdm2 gene is a target for activation by wt p53. In view of the ability of mdm2 to act as a specific antagonist of p53 activity, this induction process may serve to tightly autoregulate p53 activity in living cells.
引用
收藏
页码:461 / 468
页数:8
相关论文
共 62 条
[51]   INVOLVEMENT OF WILD-TYPE P53 IN PRE-B-CELL DIFFERENTIATION INVITRO [J].
SHAULSKY, G ;
GOLDFINGER, N ;
PELED, A ;
ROTTER, V .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (20) :8982-8986
[52]   INDUCTION OF APOPTOSIS BY WILD-TYPE P53 IN A HUMAN COLON TUMOR-DERIVED CELL-LINE [J].
SHAW, P ;
BOVEY, R ;
TARDY, S ;
SAHLI, R ;
SORDAT, B ;
COSTA, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) :4495-4499
[53]  
SHOHATFOORD O, 1991, NUCLEIC ACIDS RES, V19, P5191
[54]  
TOMINAGA O, 1992, Critical Reviews in Oncogenesis, V3, P257
[55]   P53 - A TRANSDOMINANT REGULATOR OF TRANSCRIPTION WHOSE FUNCTION IS ABLATED BY MUTATIONS OCCURRING IN HUMAN CANCER [J].
UNGER, T ;
NAU, MM ;
SEGAL, S ;
MINNA, JD .
EMBO JOURNAL, 1992, 11 (04) :1383-1390
[56]   P53 FUNCTION AND DYSFUNCTION [J].
VOGELSTEIN, B ;
KINZLER, KW .
CELL, 1992, 70 (04) :523-526
[57]   THE MCK ENHANCER CONTAINS A P53 RESPONSIVE ELEMENT [J].
WEINTRAUB, H ;
HAUSCHKA, S ;
TAPSCOTT, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (11) :4570-4571
[58]   INHIBITION OF P53 TRANSACTIVATION REQUIRED FOR TRANSFORMATION BY ADENOVIRUS EARLY 1B-PROTEIN [J].
YEW, PR ;
BERK, AJ .
NATURE, 1992, 357 (6373) :82-85
[59]   MONOCLONAL-ANTIBODY ANALYSIS OF P53 EXPRESSION IN NORMAL AND TRANSFORMED-CELLS [J].
YEWDELL, JW ;
GANNON, JV ;
LANE, DP .
JOURNAL OF VIROLOGY, 1986, 59 (02) :444-452
[60]   WILD-TYPE P53 INDUCES APOPTOSIS OF MYELOID LEUKEMIC-CELLS THAT IS INHIBITED BY INTERLEUKIN-6 [J].
YONISHROUACH, E ;
RESNITZKY, D ;
LOTEM, J ;
SACHS, L ;
KIMCHI, A ;
OREN, M .
NATURE, 1991, 352 (6333) :345-347